In summary, this study indicates that miR-1202 is upregulated in BPH; miR-1202 promotes epithelial cell proliferation, inhibits cell apoptosis, and promotes the EMT process by targeting HMGCL. The gene discussed is HMGCL; the disease is benign prostatic hyperplasia.